New Key Statistics Module, Z-Score and F-Score
SZSE:002412 Key Ratios
Market Cap ¥ M | 3,321.12 |
Enterprise Value ¥ M | 3,004.93 |
P/E(ttm) | 14.70 |
PE Ratio without NRI | 14.44 |
Forward PE Ratio | -- |
Price/Book | 1.58 |
Price/Sales | 3.45 |
Price/Free Cash Flow | 18.51 |
Price/Owner Earnings | 22.37 |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 965.00 |
EPS (TTM) ¥ | 0.45 |
Beneish M-Score | -2.3 |
10-y EBITDA Growth Rate % | 6.10 |
5-y EBITDA Growth Rate % | 3.90 |
y-y EBITDA Growth Rate % | 56.30 |
EV-to-EBIT | 11.50 |
EV-to-EBITDA | 11.50 |
PEG | 3.70 |
Shares Outstanding M | 503.20 |
Net Margin (%) | 23.41 |
Operating Margin % | 26.01 |
Pre-tax Margin (%) | 26.78 |
Quick Ratio | 2.52 |
Current Ratio | 3.20 |
ROA % (ttm) | 9.50 |
ROE % (ttm) | 11.26 |
ROIC % (ttm) | 11.92 |
Dividend Yield % | -- |
Altman Z-Score | 7.06 |
SZSE:002412 Number of Guru Trades
SZSE:002412 Volume of Guru Trades
Gurus Latest Trades with SZSE:002412
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002412 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hunan Hansen Pharmaceutical Co Ltd Insider Transactions
No Available Data